Skip to content
Agriculture Farming Rural, Science

Stepping up adoption of genomics on farm

Illumina 3 mins read

 

Partnership announcement - Stepping Up Adoption of Genomics on Farm

With the rising challenges of feeding a global population and a changing climate, the time is now to unlock the power of genomic data to make a meaningful difference on-farm.

Illumina (NASDAQ: ILMN), a leading global biotechnology company, has teamed up with AbacusBio, a global agri-science consultancy firm, in a move expected to deliver significant real-world value to agriculture around the world by driving up the rate of genetic improvement in the livestock, cropping, aquaculture, horticulture and forestry sectors.

Genomics has already transformed plant and animal research and biotechnology in the past two decades. This has played a critical role in developing crops that can thrive in less hospitable climates and selecting livestock traits for better productivity on farm. It is quickly becoming a best-practice tool supporting complex breeding programs that aim to achieve greater efficiency and sustainability in agricultural production. Today, accessibility of genomics technologies developed by Illumina has set the stage for genetic improvement and genomics-enabled breeding in many species.

AbacusBio, with its origin and headquarters in Ōtepoti Dunedin, Aotearoa New Zealand, spans across the globe with international offices in Edinburgh, UK and in Edmonton, Canada. The company offers value-chain and genetic improvement program consulting, as well as other consulting services related to livestock and crops. Illumina’s global reach combined with AbacusBio’s extensive experience in implementing selective breeding programs will accelerate transformation of breeding practices towards achieving greater sustainability of agricultural production.

“We are proud to partner with a globally recognised brand to deliver impact, particularly with an emphasis on exciting new genetic improvement opportunities in countries with rapidly developing agriculture sectors,” AbacusBio Group Managing Director, Dr Peter Amer, said.

Illumina is dedicated to making tangible contributions to the agricultural community, with the goal of reducing hunger, malnutrition, and poverty through the development of affordable and accessible sequencing technology.

“Changing environmental conditions and consumer preferences around the world have a significant impact on farm economics and sustainability of agricultural production. This common challenge unites us, as the provision of nutritious and readily available food is necessary to sustain life right around the world,” Evgeny Glazov, Senior Market Development Manager at Illumina, said.

“We aim to foster adoption of best practices and technology that will result in increased sustainability, improved economics, and nutritional density of agricultural production. This partnership with AbacusBio is key to bringing our combined expertise to countries and organizations that are looking to adapt their practices to meet the challenges of supplying the world with healthy and nutritious food in a sustainable way,” Evgeny said.

Dr Bruno Santos, a Consulting Partner and Director at AbacusBio, said this partnership is a great opportunity to build on the expertise of both companies worldwide. “Our projects focused on smallholder farming and cropping systems in several African countries and in India will benefit from the combined value of local knowledge, Illumina’s experience, and AbacusBio’s expertise in leveraging genetic improvement to generate commercial outcomes and impact.”

“We see excellent alignment of the strategic goals between AbacusBio and Illumina”, Managing Director of AbacusBio International (UK), Dr Tim Byrne, said. He believes this collaboration will open more avenues for both parties to better provide technical services to global organisations involved in improving crops and livestock.

A close-up of a chartDescription automatically generated


About us:

About Illumina
Illumina is helping sustain the planet by unlocking the power of the genome. In 2023, we celebrate 25 years of innovation, which has established us as a global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical, and applied markets. Our products are used for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. To learn more, visit illumina.com and connect on X(Twitter),  FacebookLinkedInInstagramTikTok, and YouTube.

About AbacusBio
AbacusBio is a world leader in providing consulting and data management services to national and international breeding organizations seeking to implement efficient selective breeding and genetic/ genomic improvement programs. They understand the importance of putting science into business practice and have been growing in the food and fibre industry at a remarkable pace. To learn more, visit AbacusBio.com and connect on LinkedIn, Twitter, Facebook, and Instagram.


Contact details:

Illumina: Peter Somerville, Currie Communications, +61 403 868 984, peter@curriecommunications.com.au

Abacus Bio: Group Managing Director, Dr Peter Amer +64 21 452 274, PAmer@abacusbio.co.nz

Media

More from this category

  • Biotechnology, Science
  • 23/12/2024
  • 09:00
Brandon Capital

CUREator + deploys $18.5 million in its first funding round

MELBOURNE, Australia — 23 December 2024 CUREator +, has announced that eight local startups developing innovations with the potential to save lives and improve wellbeing will receive grants totalling $18.5 million in its first funding round. CUREator+, delivered in partnership with Brandon BioCatalyst and ANDHealth, is a national program focused on accelerating the research translation and commercialisation of preclinical and clinical early-stage Australian medical research and medical innovations with commercial potential. These innovations include drugs (novel and repurposed), devices, diagnostics and digital technologies that address unmet needs. Enabling rapid assessment of the efficacy of cancer treatments AI-powered platform providing early…

  • General News, Science
  • 19/12/2024
  • 10:00
Australian National Maritime Museum

DEEPSEA CHALLENGER returns home to Sydney in brand-new Maritime Museum exhibition

The Australian National Maritime Museum is thrilled to become the temporary home of the DEEPSEA CHALLENGER, the iconic submersible which took James Cameron to the deepest trenches of the ocean in 2012. It features within a brand-new exhibition, Ultimate Depth: A Journey to the Bottom of the Sea, opening on December 19, 2024. The DEEPSEA CHALLENGER, was designed, tested, and engineered in Sydney, was co-engineered by the renowned Ron Allum, a local Sydney cave diver, engineer, deep-sea explorer and former NSW Senior Australian of the Year. The Museum is honoured to have Ron Allum visit the exhibition for its launch…

  • Contains:
  • Engineering, Science
  • 19/12/2024
  • 09:00
UNSW Sydney

This purple diamond could one day amplify signals from deep space

They say that diamonds are a girl’s best friend – but that might also soon be true for astronomers and astrophysicists following new research…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.